Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer
Clinical trial NCT02690948 · COMPLETED
Trial details
- NCT number
- NCT02690948
- Sponsor
- Anne Chang
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-11-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.